This month's issue of the American Journal of Gastroenterology outlines the mechanisms by which central neuromodulators work, the differences between classes and individual agents, and the various adverse effects.
A study published in May's issue of the Alimentary Pharmacology & Therapeutics evaluates the short- and long-term impact of Clostridium difficile infection on risk of colectomy in inflammatory bowel disease.
Published ahead of print, the Alimentary Pharmacology & Therapeutics reports that risk factors for non-alcoholic fatty liver disease suggest a shared altered metabolic and cardiovascular profile between lean and obese patients.
A study in this month's issue of the Annals of Internal Medicine summarizes published literature on the efficacy and safety of oral direct-acting antivirals for treatment of persons with chronic HCV infection.
The most recent issue of the Alimentary Pharmacology & Therapeutics quantified the cumulative incidence of HCC among a representative population of people with cirrhosis of the liver of varying etiology.
April's issue of Gut validated the IBD-DI in an independent patient cohort, to develop an index-specific scoring system, and to describe the disability status of a well-defined population-based cohort of French patients with IBD.
A genome-wide association study reported in May's issue of Gastroenterology identifies TLL1 variant associated with development of hepatocellular carcinoma after eradication of Hepatitis C virus infection.